Objective: To optimize full-process information management of allergy drugs in women and children’ s Hospital

so as to improve the safety of patients using allergic drugs. Methods: Deficiencies in the full-process management of allergic drugs in the hospital were sort out. Intervention measures in accordance with the Guideline for Skin Testing of β Lactam Antibiotics ( 2021 Edition) by National Health Commission were formulated

and the existing management model was optimized. Results: The hospital policies were updated

including the cancellation of routine skin testing for cephalosporin antibiotics and establishment of prescribing process for β lactam antibiotics. The department of pharmacy formulated the inclusion criteria for the allergy drug list and updated the allergy drug list. The information management of allergic drugs by hospital information system(HIS) in outpatient

emergency and inpatient was optimized from the clinician

pharmacist and nursing perspectives. After optimizing the full-process management of allergic drugs

there were no significant changes in the number of penicillin skin tests

quantity of test drugs

cost of testing

positive rate of skin tests

and incidence of adverse drug reactions. In contrast

cephalosporins showed significant decrease in the number of skin tests

quantity of test drugs

cost of testing and positive rate of skin tests

except for the incidence of adverse drug reactions

which did not change significantly. Conclusion: By updating institutional policies and optimizing information system

it is beneficial to promote standardized and information-based management of allergic drugs throughout the full-process

which helps improve the quality of medical services in the hospital and enhances patients’ satisfaction.